Ana Sofia Ferreira
Advertisement
Articles by Ana Sofia Ferreira
Advertisement
![TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bb58c5f3c3692dc35c19320bb63c3df864f9b79b-1500x722.png?w=300&fit=crop&auto=format)
Advertisement
Advertisement
Trending on CancerNetwork
1
EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process
2
Risvutatug Rezetecan Improves Overall Survival in Relapsed SCLC Trial
3
Orca-T Improves Chronic GVHD-Free Survival in Hematologic Cancers
4
TIP12 Validation of a Multimodal Artificial Intelligence Prognostic Model in Early-Stage HR+/HER2− Breast Cancer
5